A Resource for Healthcare and Social Services Professionals
This course educates physicians, nurse practitioners, and physician assistants on prescribing buprenorphine for the treatment of opioid use disorder, with particular attention to the treatment of women during pregnancy and postpartum.
This free eight-hour course prepares physicians, nurse practitioners and physician assistants to prescribe buprenorphine to treat opioid use disorder in their office. The curriculum includes the science of addiction as a brain disorder, the pharmacology of buprenorphine, and the regulatory requirements around prescribing this medication. Attendees will learn to screen patients for treatment with buprenorphine and to manage the medication along with the patient's other medical needs in an office setting such as a primary care clinic. The course fulfills 8 hours of the training needed to obtain a waiver to prescribe buprenorphine. The Drug Addiction Treatment Act of 2000 (DATA 2000) requires physicians to complete 8 hours of approved training in order to be eligible for a waiver, and nurse practitioners and physician assistants to complete 24 hours.
Check-in for the course will be from 7:30am to 8:00am and the training will run from 8:00am to 4:30pm. Breakfast and lunch will be provided. This is an in-person training. There will not be an option to attend via webinar.
At the conclusion of this activity, participants should be able to:
● Screen and identify patients with OUD and define evidence-based treatments.
● Discuss the pharmacology of opioids as it relates to treatment of opioid use disorder (OUD) patients.
● Describe the fundamentals of office-based opioid treatment including the treatment of the co-morbid patient.
● Explain the process of buprenorphine induction as well as stabilization and maintenance.
● Discuss all FDA approved antagonist and agonist medications to treat OUD.
● Discuss basic office protocols including medical record documentation and confidentially.
● Utilize evidence-based resources to ensure providers have the confidence to prescribe buprenorphine for patients with OUD.
● Recognize the importance of obtaining a waiver to begin treating patients with OUD.
Physicians (MD, DO), Nurse Practitioners, and Physician Assistants
Boston Medical Center Grayken Center for Addiction, Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS).
American Academy of Addiction Psychiatry (AAAP) is the DATA 2000 sponsor for this training.
Funding for this initiative was made possible (in part) by grant no. 1H79TI081968-01 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Joint Accreditation Statement: In support of improving patient care, this activity has been planned and implemented by the Boston Medical Center Grayken Center for Addiction, Massachusetts Department of Public Health , the Bureau of Substance Abuse Services and American Academy of Addiction Psychiatry. American Academy of Addiction Psychiatry is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credential Center (ANCC) to provide continuing education for the healthcare team.
In 2019, AAAP also added accreditation from The American Academy of PAs (AAPA), American Psychological Association (APA) and Association for Social Work Boards (ASWB).
Interprofessional Continuing Education (IPCE) Designation Statement: This activity was planned by and for the healthcare team, and learners will receive 8 (eight) Interprofessional Continuing Education credits for learning and change.
Physician Designation Statement: American Academy of Addiction Psychiatry designates this live activity for a maximum of 8 (eight) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Designation Statement: American Academy of Addiction Psychiatry is an approved provider of nursing continuing education through AAAP's Joint Accreditation provider #4008192. This program is approved for up to 8 Nursing Contact Hours.
PA Designation Statement: American Academy of Addiction Psychiatry has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for a maximum of 8 AAPA Category 1 CME credits. Approval is valid until 12/31/2020. PAs should only claim credit commensurate with the extent of their participation.